DEEPTECH Kobe University Team Shows iPS-derived Immune Cells Attack Colon Tumors in Lab Trial
Researchers demonstrated high anti-tumor efficacy against patient-derived colorectal cancer tissue using gamma-delta T cells generated from iPS cells, targeting off-the-shelf immunotherapy.





